Search

everythinglearnresearchcommunity

for

Search:↓

The document explains how to make a compound called 3.BETA.-Benzoyloxy-4-pregnen-16.ALPHA.,17.ALPHA.-epoxy-6,20-dione and describes its crystal structure.

TrichoSol™ effectively stabilizes various hair treatment ingredients for different durations.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Certain chemical changes to cortisol and progesterone can increase or decrease their ability to inhibit hair growth.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Hydrocortisone 17-butyrate 21-propionate ointment caused reversible side effects like skin issues, weight gain, and organ changes in dogs.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

A new method was developed to make finasteride for treating hair loss.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

A new method to make finasteride for hair loss treatment was developed.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Method B with propylene glycol is better for stable low-concentration DPCP solutions for alopecia areata.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

In 2017, a new method was created to efficiently produce a topical antiandrogen, a compound used to treat excess sebum and acne, with a high yield and purity.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

An 8-year-old boy with hair loss had hair regrowth and responded well to clobetasol propionate treatment.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.